Advancing the Future of Healing: The Story Behind ReyaGel®
“After witnessing what felt like miracles helping wounded patients heal in the hospital, Clay and I dedicated our lives to advancing regenerative medicine - so more patients have the chance to heal!”
Read the full story below.
Founders
ReyaGel was inspired by what we witnessed every day in the hospital.
As a wound care nurse, Danielle cared for patients with severe burns, trauma, and complex wounds. During that time, she saw firsthand the powerful role extracellular matrix (ECM) could play in supporting the body’s natural healing process. Wounds that once seemed impossible to heal began to close. Patients recovered in ways that felt extraordinary.
In many cases, it wasn’t just about improving healing — it was about saving lives.
For more than 25 years, Clay has helped develop extracellular matrix technologies used by surgeons and clinicians around the world. With each generation of innovation, he continued refining how ECM could be processed and applied—making the technologies more advanced, more versatile, and better able to support healing.
But we believed the field could go even further.
At the time, extracellular matrix products existed primarily in solid forms. We saw an opportunity to push the technology forward by developing a liquid extracellular matrix, creating a more flexible platform with new possibilities for physicians.
At the same time, Clay—a tissue engineer and pioneer in regenerative medicine—was developing the technologies surgeons and clinicians relied on to help those same patients heal.
Seeing the impact ECM could have on patients inspired us to ask a bigger question:
How could we advance this technology even further to help more people heal?
That belief led to the development of our Multi-Tissue Platform (MTP®).
First introduced in hospitals as a powder used to support healing in severe wounds and surgical applications, the technology has helped thousands of patients. Continuing to advance that work ultimately led to the development of ReyaGel, the first FDA-cleared liquid extracellular matrix.
Today, physicians are exploring how this technology may support healing across multiple areas of medicine, including wound care, surgery, and aesthetic procedures.
“We are all going to be patients one day, and we feel the urgency to get better products to the patients that need them faster. ”
ReyaGel was created by a husband-and-wife team driven by a shared mission to advance healing.